Journals / Dicle Tıp Dergisi / 2023 / Cilt: 50 Sayı: 2 - Cilt 50, Sayı 2

Management of Cardiac Implantable Electronic Devices removal with cardiopulmonary bypass: A single center experience

Pages
187–193
Publication Date
2023-06-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this reason, we believe that it should be beneficial to consider the long-term results in determining permanent pacemaker and internal defibrillator indications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Backround: Currently, permanent pacemakers and internal defibrillators are widely used as a result of technological developments.
📊
Key Findings & Data:Methods: Between June 2017 and October 2019, 667 CIED were implanted and 10 patients underwent surgical removal of CIED in our hospital.
💡
Conclusion & Impact:For this reason, we believe that it should be beneficial to consider the long-term results in determining permanent pacemaker and internal defibrillator indications.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Cardiac implantable electronic device · cardiopulmonary bypass · cardiac pacemaker

Abstract

Backround: Currently, permanent pacemakers and internal defibrillators are widely used as a result of technological developments. Infection and dysfunction are the most important reasons for removing these devices from patients. Transvenous removal of these devices is the first recommended method. Failure of transvenous methods, presence of endocarditis, large vegetation or thrombus requires the use of surgical methods to remove these devices. In this study, our purpose is to present our management in surgical removal of cardiac implantable electronic devices (CIED). Methods: Between June 2017 and October 2019, 667 CIED were implanted and 10 patients underwent surgical removal of CIED in our hospital. The demographic data of the patients were obtained from the polyclinic files and the hospital registration system. Results: Eight (80%) patients were male and the mean age was 55.3±16.4 years (22.0-77.0). Complete pacemaker system removal was decided by the heart team in all cases. In 4 patients, permanent pacemaker reimplantation was required intraoperatively. Conclusion: CIED infection is a serious disease associated with high mortality. For this reason, we believe that it should be beneficial to consider the long-term results in determining permanent pacemaker and internal defibrillator indications.

🔖

Cite This Article

AKSU, T., USTUNİSİK, C. T. (2023). Management of Cardiac Implantable Electronic Devices removal with cardiopulmonary bypass: A single center experience. Dicle Tıp Dergisi, Cilt: 50 Sayı: 2 - Cilt 50, Sayı 2, 187–193. https://ajindex.com/articles/939512

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or animplantable cardioverter-defibrillator for congestiveheart failure. N Engl J Med. 2005
  2. 352(3):225–37. 2.Linde C, Abraham WT, Gold MR, et al. Randomizedtrial of cardiac resynchronization in mildlysymptomatic heart failure patients and inasymptomatic patients with left ventriculardysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008
  3. 52(23):1834–43. 3.Moss AJ, Hall WJ, Cannom DS, et al. Cardiacresynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009
  4. 361(14):1329–38. 4.Cazeau S, Leclercq C, Lavergne T, et al. Effects ofmultisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001
  5. 344(12):873–80. 5.Voigt A, Shalaby A, Saba S. Continued rise in rates ofcardiovascular implantable electronic deviceinfections in the United States: temporal trends andcausative insights. Pacing Clin Electrophysiol.2010
  6. 33(4):414–9. 6.Margey R, McCann H, Blake G, et al. Contemporarymanagement of and outcomes from cardiac devicerelated infections. Europace 2010
  7. Baddour LM, Epstein AE, Erickson CC, et al. Updateon cardiovascular implantable electronic deviceinfections and their management: a scientificstatement from the American Heart Association.Circulation 2010
  8. Kantharia BK, Kutalek SP. Extraction of pacemakerand implantable cardioverter defibrillator leads. CurrOpin Cardiol 1999 Jan
  9. 14(1):44-51. 9.Colavita PG, Zimmern SH, Gallgher JJ, et al.Intravascular extraction of chronic pacemaker leads:efficacy and follow up: Pacing Clin Electrophysiol 1993 Dec
  10. 16(12):2333-6. 10.Farooqi FM, Talsania S, Hamid S, et al. Extraction of cardiac rhythm devices: indications, techniques andoutcomes for the removal of pacemaker anddefibrillator leads. Int J Clin Pract 2010
  11. Brodman R, Frame R, Andrews C, et al. Removal ofinfected transvenous leads requiring cardiopulmonary bypass or inflow occlusion. J Thorac Cardiovasc Surg1992
  12. Frame R, Brodman R, Furman S et al. Surgicalremoval of infected transvenous pacemaker leads.Pace 1993 Dec
  13. Li JS, Sexton DJ, Mick N, et al. Proposedmodifications to the Duke criteria for the diagnosis ofinfective endocarditis. Clin Infect Dis 2000
  14. 633–8. 14.Bongiorni MG, Burri H, Deharo JC, et al. 2018 EHRAexpert consensus statement on lead extraction:recommendations on definitions, endpoints, researchtrial design, and data collection requirements fo